Initial Clinical Experience With AneuFix Injectable Biocompatible Elastomer for Translumbar Embolization of Type 2 Endoleaks.
Stefan P M SmorenburgRutger J LelyBas-Jeroen van KelckhovenErik G VermeulenKak Khee YeungRombout R KruseMartin KraaiChrit M StassenMichael J JacobsArjan W J HoksbergenPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2023)
Effective and durable embolization of type II endoleaks causing abdominal aortic aneurysms (AAA) growth after EVAR is challenging. A novel injectable elastic polymer (elastomer) was developed, specifically designed to treat type II endoleaks (AneuFix, TripleMed, Geleen, the Netherlands). Embolization of the type II endoleak was performed by translumbar puncture. The viscosity changes from paste-like during injection, into an elastic implant after curing. The initial experience of this multicentre prospective pivotal trial demonstrated that the procedure is feasible and safe with a technical success of 100%. Absence of AAA growth was observed in 9 out of 10 treated patients at 6 months.